With the change in season, a familiar wave of sneezes, coughs, and fevers begins to spread. It signals the return of respiratory viruses. These viruses can infect the upper respiratory tract (like ...

Many people with COPD don’t notice the early symptoms. Here's how to spot subtle signs, get diagnosed early, and explore new ...

The toddler's symptoms, however, suddenly worsened on the ride home ... you are assuming something like strep throat, RSV, ...

Expert doctors in infectious disease and lung health speak to the transmissibility of walking pneumonia and more infection ...

The virus poses a more serious risk to high-risk groups such as the elderly, young children, and individuals with chronic ...

Maternal respiratory syncytial virus (RSV) vaccination and nirsevimab were associated with a reduction in RSV-associated ...

New multi-center US study finds RSV co-infection in children under two is not linked to worse clinical outcomes, challenging ...

New respiratory syncytial virus (RSV) prevention products significantly reduce infant hospitalization rates, highlighting the ...

Two preventive tools — a maternal vaccine and a monoclonal antibody — were tied to a recent drop in RSV hospitalization rates for U.S. babies.

A single dose of the adult RSV vaccine RSVPreF3 OA prevented RSV–lower respiratory tract disease during 3 virus seasons in adults aged 60+.

Maternal RSV vaccination and nirsevimab were associated with a reduction in RSV hospitalization rates in infants aged 0 to 7 months during the 2024-2025 RSV season.

Maternal RSV vaccination and nirsevimab were associated with a reduction in hospitalization rates among infants aged 0 to 7 months.